Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir

OBJECTIVE: Atazanavir (ATV) and lopinavir (LPV) have been associated with kidney disease progression in HIV positive patients, with no data reported for darunavir (DRV). We examined kidney function in patients who switched their protease inhibitor from ATV or LPV to DRV. DESIGN: Cohort study. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: Jose, Sophie, Nelson, Mark, Phillips, Andrew, Chadwick, David, Trevelion, Roy, Jones, Rachael, Williams, Deborah I., Hamzah, Lisa, Sabin, Caroline A., Post, Frank A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278893/
https://ncbi.nlm.nih.gov/pubmed/28121667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados